Anne M Suskind1, Christopher S Saigal2, Janet M Hanley3, Julie Lai3, Claude M Setodji3, J Quentin Clemens4. 1. Department of Urology, University of California, San Francisco, San Francisco, CA. Electronic address: Anne.Suskind@ucsf.edu. 2. Department of Urology, University of California, Los Angeles, Los Angeles, CA. 3. RAND Corporation, Santa Monica, CA. 4. Department of Urology, University of Michigan, Ann Arbor, MI.
Abstract
OBJECTIVE: To determine the incidence and characteristics of women with uncomplicated recurrent urinary tract infections (UTIs) and to explore whether the use of culture-driven treatment affects rates of UTI-related complications and resource utilization. MATERIALS AND METHODS: Using MarketScan claims from 2003 to 2011, we identified UTI-naive women ages 18-64 with incident-uncomplicated recurrent UTIs. Recurrent UTIs were defined as 3 UTI visits associated with antibiotics during a 12-month period. Cases were excluded if they had a UTI in the preceding year, or if they had any complicating factors (eg, abnormality of the urinary tract, neurologic condition, pregnancy, diabetes, or currently taking immunosuppression). We next assessed use of urine cultures, imaging, and cystoscopy, and performed propensity score matching with logistic regression to determine whether having a urine culture associated with >50% of UTIs affected rates of complications and downstream resource utilization. RESULTS: We identified 48,283 women with incident-uncomplicated recurrent UTIs, accounting for an overall incidence of 102 per 100,000 women, highest among women ages 18-34 and 55-64. Sixty-one percent of these women had at least 1 urine culture, 6.9% had imaging, and 2.8% had cystoscopy. Having a urine culture >50% of the time was associated with fewer UTI-related hospitalizations and lower rates of intravenous antibiotic use, whereas demonstrating higher rates of UTI-related office visits and pyelonephritis. CONCLUSION: The incidence of uncomplicated recurrent UTIs increases with age. Urine culture-directed care is beneficial in reducing high-cost services including UTI-related hospitalizations and intravenous antibiotic use, making urine cultures a valuable component to management of these patients.
OBJECTIVE: To determine the incidence and characteristics of women with uncomplicated recurrent urinary tract infections (UTIs) and to explore whether the use of culture-driven treatment affects rates of UTI-related complications and resource utilization. MATERIALS AND METHODS: Using MarketScan claims from 2003 to 2011, we identified UTI-naive women ages 18-64 with incident-uncomplicated recurrent UTIs. Recurrent UTIs were defined as 3 UTI visits associated with antibiotics during a 12-month period. Cases were excluded if they had a UTI in the preceding year, or if they had any complicating factors (eg, abnormality of the urinary tract, neurologic condition, pregnancy, diabetes, or currently taking immunosuppression). We next assessed use of urine cultures, imaging, and cystoscopy, and performed propensity score matching with logistic regression to determine whether having a urine culture associated with >50% of UTIs affected rates of complications and downstream resource utilization. RESULTS: We identified 48,283 women with incident-uncomplicated recurrent UTIs, accounting for an overall incidence of 102 per 100,000 women, highest among women ages 18-34 and 55-64. Sixty-one percent of these women had at least 1 urine culture, 6.9% had imaging, and 2.8% had cystoscopy. Having a urine culture >50% of the time was associated with fewer UTI-related hospitalizations and lower rates of intravenous antibiotic use, whereas demonstrating higher rates of UTI-related office visits and pyelonephritis. CONCLUSION: The incidence of uncomplicated recurrent UTIs increases with age. Urine culture-directed care is beneficial in reducing high-cost services including UTI-related hospitalizations and intravenous antibiotic use, making urine cultures a valuable component to management of these patients.
Authors: R Ikäheimo; A Siitonen; T Heiskanen; U Kärkkäinen; P Kuosmanen; P Lipponen; P H Mäkelä Journal: Clin Infect Dis Date: 1996-01 Impact factor: 9.079
Authors: Amee R Manges; Hyun Min Geum; Alice Guo; Thaddeus J Edens; Chad D Fibke; Johann D D Pitout Journal: Clin Microbiol Rev Date: 2019-06-12 Impact factor: 26.132
Authors: Megan S Bradley; Michael Stanger; Cassie Ford; Jerry Lowder; Victoria L Handa Journal: Female Pelvic Med Reconstr Surg Date: 2022-04-01 Impact factor: 1.913
Authors: Stacy M Lenger; Christine M Chu; Chiara Ghetti; Michael J Durkin; Zoe Jennings; Siobhan Sutcliffe; Jerry L Lowder Journal: Female Pelvic Med Reconstr Surg Date: 2022-06-01 Impact factor: 1.913
Authors: Nicole A Meckes; Alexandra I Melnyk; Marina Guirguis; Halina Zyczynski; Megan S Bradley Journal: Female Pelvic Med Reconstr Surg Date: 2022-04-15 Impact factor: 1.913
Authors: Kimberley Chiu; Fan Zhang; Siobhan Sutcliffe; Indira U Mysorekar; Jerry L Lowder Journal: Female Pelvic Med Reconstr Surg Date: 2022-03-01 Impact factor: 2.091